CC
RVNC

CIBRA Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

CIBRA Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,139,979
Closed -$3.47M – 36
2024
Q4 		$3.47M Buy
+1,139,979
New +$4.97M 2.36% 13

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CIBRA Capital's RVNC Position: Q1 2025 in Review

CIBRA Capital sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 1,139,979 shares — an estimated $3.47M sold.

CIBRA Capital first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $3.47M in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • CIBRA Capital reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • CIBRA Capital sold 1,139,979 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $3.47M.
  • CIBRA Capital first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
  • CIBRA Capital's Revance Therapeutics, Inc. position peaked at $3.47M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.